Related Experiment Video

Updated: Nov 27, 2025

Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes
10:03

Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes

Published on: November 11, 2016

10.1K

Strategies for Cancer Immunotherapy Using Induced Pluripotency Stem Cells-Based Vaccines

Bruno Bernardes de Jesus1, Bruno Miguel Neves1, Manuela Ferreira2,3

  • 1Department of Medical Sciences and Institute of Biomedicine-iBiMED, University of Aveiro, 3810-193 Aveiro, Portugal.

Cancers
|December 3, 2020
PubMed

Insights

Patient-derived induced pluripotent stem cells (iPSCs) show promise for cancer immunotherapy. Their similarities to cancer cells could lead to new patient-specific vaccines and treatments for refractory tumors.

Area of Science:

  • Oncology
  • Immunology
  • Stem Cell Biology

Background:

  • Metastatic solid tumors are difficult to treat, and current immunotherapies face challenges with antigen presentation and tumor refractoriness.
  • Immunotherapy, including immune checkpoint blockade and CAR T-cell therapy, has shown success but is not universally effective.
  • Patient-derived induced pluripotent stem cells (iPSCs) share characteristics with cancer stem cells (CSCs) and can elicit anti-tumor responses.

Purpose of the Study:

  • To review the potential of cellular reprogramming and iPSCs in developing patient-specific immunotherapies.
  • To discuss the parallels between iPSCs and cancer cells in the context of immunotherapy.
  • To explore strategies for enhancing the efficacy of iPSC-based cancer vaccines.

Main Methods:

  • Literature review and discussion of existing research on iPSCs, cancer stem cells, and immunotherapy.
  • Analysis of the similarities between iPSCs and cancer cells regarding immunogenicity.
  • Exploration of potential therapeutic strategies leveraging iPSCs for cancer treatment.

Main Results:

  • iPSCs exhibit characteristics similar to CSCs, suggesting their potential as a basis for anti-cancer immune responses.
  • Cellular reprogramming offers a pathway to generate patient-specific cellular therapies.
  • Further strategies are needed to optimize iPSC-based vaccines for improved therapeutic outcomes.

Conclusions:

  • iPSCs hold significant potential for developing personalized cancer immunotherapy strategies.
  • Understanding the iPSC-cancer cell relationship is key to unlocking their therapeutic value.
  • Enhancing iPSC immunogenicity could lead to more effective cancer vaccines for difficult-to-treat malignancies.
Keywords:
canceriPSCsimmunotherapyneoantigensreprogrammingvaccines

More Related Videos

Using Human Induced Pluripotent Stem Cells for the Generation of Tumor Antigen-specific T Cells10:57

Using Human Induced Pluripotent Stem Cells for the Generation of Tumor Antigen-specific T Cells

Published on: October 24, 2019

10.7K
Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells12:43

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

12.1K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
899
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
677
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.9K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
25.7K
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.1K
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.9K